PROS1 and neoplasm: When we observed tumors measuring around 50 mm3 in all tumor-bearing mice, they were treated with aAVC-PSMA (Figure 5A), aAVC-PSA (Figure 5B), or aAVC-PAP (Figure 5C), respectively.